Tim Boreham, Stockhead's small caps correspondent joins The Australian's Wealth Editor James Kirby on this week's show. They discuss how Biotech gets hit hardest of all, one reason this sector may recover first and three ASX biotech stocks for you to consider.
See omnystudio.com/listener for privacy information.
Published on 3 years, 7 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate